Information about the Bruton tyrosine kinase (BTK) inhibitor ibrutinib (Imbruvica), commonly used in hematologic neoplasms.
How useful was this post?
Please, click on a star to rate it!
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this post.
